Citations

Clear

4847 citation(s) found for "Tu, Eric".

Analysis of demographics and the impact of adjuvant radiotherapy on a nationwide cohort of patients with high-grade spinal meningiomas
El-Hajj, Victor Gabriel , Saïdi, N. , Hoang, Harry , Graepel, Stephen , Elmi‐Terander, Adrian , Lehrer, Eric J. , Brown, Paul D. , Bydon, Mohamad , Al-Saidi, Neil Nazar, Graepel, Stephen P, Elmi-Terander, Adrian , El-Hajj, Victor Gabriel , Al-Saidi, Neil Nazar , Ghaith, Abdul Karim , Nguyen, Ryan H

Mayo Clinic

Neuro-Oncology Advances | February 5, 2024 | Volume: 6 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdae018 | PMID 38410135 Get It

Abstract Background Although typically benign, 5% of spinal meningiomas (SMs) present with higher-grade features (World Health Organization grades 2 and 3). High-grade SMs are poorly studied and the role of adjuvant radiotherapy in their management remains controversial. We hence aimed to study the demographic characteristics of this rare tumor and investigate the outcomes associated with the use of surgery with adjuvant therapy in contrast to surgery alone. Methods The National Cancer Database was queried for patients with SMs from 2004 to 2017. Basic statistics were used to identify differences between low- and high-grade tumors in terms of baseline characteristics. Surgery with and without adjuvant radiotherapy were compared after (1:1) propensity-score matching. Kaplan–Meier survival analysis was conducted to study overall survival. All analyses were performed on R. Results A total of 13 184 patients diagnosed with SMs were included, of whom only 5% (n = 669) had high-grade SMs. Patients with high-grade SMs presented at a younger median age (57 years [IQR: 44–68] versus 65 years [54–75]; P < .001) and were more commonly males (33% vs 20%; P < .001). After propensity-score matching, survival analysis revealed similar overall survival outcomes in patients with high-grade SM undergoing both surgery and radiotherapy as compared to those only receiving surgery (P = .19). Conclusions This study reveals major demographic differences between high- and low-grade SMs. There were no benefits associated with the use of adjuvant radiotherapy. However, due to confounding, overall survival outcomes between patients receiving surgery alone and those receiving surgery with adjuvant radiotherapy are not causally interpretable.
Associations between plasma metabolism-associated proteins and future development of giant cell arteritis: results from a prospective study
Wadström, Karin , Jacobsson, L. , Mohammad, Aladdin J , Warrington, Kenneth J. , Matteson, Eric L. , Jakobsson, Magnus E. , Turesson, Carl , Jacobsson, Lennart , Warrington, Kenneth J , Mohammad, Aladdin J , Turesson, Carl

Mayo Clinic

Rheumatology | February 4, 2024 | Volume: 64 | Issue: 2 | Pages: 714-721

10.1093/rheumatology/keae073 | PMID 38310345 Get It

Abstract Objective The aim of this study was to investigate the relationship between biomarkers associated with metabolism and subsequent development of GCA. Method Participants in the population-based Malmö Diet Cancer Study (MDCS; N = 30 447) who were subsequently diagnosed with GCA were identified in a structured process. Matched GCA-free controls were selected from the study cohort. Baseline plasma samples were analysed using the antibody-based OLINK proteomics metabolism panel (92 metabolic proteins). Analyses were pre-designated as hypothesis-driven or hypothesis-generating. In the latter, principal component analysis was used to identify groups of proteins that explained the variance in the proteome. Results There were 95 cases with a confirmed incident diagnosis of GCA (median 12.0 years after inclusion). Among biomarkers with a priori hypotheses, adhesion G protein-coupled receptor E2 (ADGRE2) was positively associated [odds ratio (OR) per S.D. 1.67; 95% CI 1.08–2.57], and fructose-1,6-bisphosphatase 1 (FBP1) was negatively associated (OR per S.D. 0.59; 95% CI 0.35–0.99) with GCA. In particular, ADGRE2 levels were associated with subsequent GCA in the subset sampled <8.5 years before diagnosis. For meteorin-like protein (Metrnl), the highest impact on the risk of GCA was observed in those patients sampled closest to diagnosis, with a decreasing trend with longer time to GCA (P = 0.03). In the hypothesis-generating analyses, elevated levels of receptor tyrosine-like orphan receptor 1 (ROR1) were associated with subsequent GCA. Conclusion Biomarkers identified years before clinical diagnosis indicated a protective role of gluconeogenesis (FBP1) and an association with macrophage activation (ADGRE2 and Metrnl) and proinflammatory signals (ROR1) for development of GCA.
A Call to Action: Urgently Strengthening the Future Physician-Scientist Workforce in Infectious Diseases
Swartz, Talia H. , Apewokin, Senu , Carpenter, Stephen M. , Chakraborty, Rana , Dennis, Ann M. , Houpt, Eric R. , Surana, Neeraj K. , Zerr, Danielle M. , Pirofski, Liise-anne , Swartz, Talia H , Pirofski, Liise‐anne

Mayo Clinic

The Journal of Infectious Diseases | February 4, 2024 | Volume: 229 | Issue: 3 | Pages: 625-629

10.1093/infdis/jiad610 | PMID 38309710 Get It

Abstract Infectious diseases (ID) research is vital for global public health, typically led by physician-scientists. This Perspective addresses challenges in the ID workforce and suggests solutions. Physician-scientists have made key discoveries that have significantly impacted human health. The importance of ID research in understanding diseases, leading to treatments and vaccines, is emphasized, along with the need to address persistent and new infections, antimicrobial resistance, and threats like HIV and influenza. The paper analyzes the physician-scientist workforce's struggles, including funding, training, and research-practice integration gaps. We suggest increased funding, better training, and mentorship, more collaborative and interdisciplinary research, and improved recognition systems. The article stresses the urgency of supporting physician-scientists in ID, advocating for proactive prevention and preparedness, and calls for immediate action to enhance ID research and care.
Abstract WMP7: Impact of Telestroke Access in a Rural Setting
Adcock, Amelia , Sarvath, Mohammed, D’Andrea, Nina, Marku, Vjosa, Petrone, Ashley , Seachrist, Eric

Mayo Clinic

Stroke | February 1, 2024 | Volume: 55 | Issue: Suppl_1 | Pages: No page available

10.1161/str.55.suppl_1.wmp7 Get It

Background: Despite decades long adoption as the standard-of-care for ischemic stroke, the majority of eligible patients do not receive intravenous thrombolysis (IVT), with underutilization especially pronounced in rural areas. Telestroke, however, may help alleviate this geographical healthcare disparity. The current study aims to identify the impact of implementing a mature telestroke network within a rural setting. Methods: Retrospective review of a prospectively maintained telestroke database from a large rural tertiary care comprehensive stroke center covering 31 spoke hospitals spanning critical access hospitals to primary stroke centers between 10/2021-02/2023. Data was compared to a previous review period (01/2016-12/2018; comprised of 8 spokes) and the statewide IVT rates recorded in GWTG. Data analysis conducted via descriptive statistics and Fisher’s (two-tailed) exact test. Results: 1801 telestroke consults were performed; 41.4% (746/1801) were ineligible for acute stroke intervention. 39% (410/1055) of eligible patients were treated with IVT (vs. 33% [317/959] previously, p = 0.068), representing 58% (410/708; vs 24% [107/448] previously, p < 0.001) of statewide total IVT administration. Symptomatic hemorrhage (sICH) was 3.0%, overall 30-day mortality was 5.6%, and sICH mortality was 1.0%. IVT deferred most commonly: low NIH (44%), mimics (21%), coagulopathy (8%), followed by other. 22% (396/1801) of total consults were transferred from the originating site (vs. 34% [305/890] previously, p < 0.0001) of which 10% (42/396) underwent EVT. Discussion: The impact of expanding a rural telestroke network continued to produce high IVT rates (nearly double the national average) with safety outcomes (sICH, mortality) at or below national standards. Additionally, a large network has significantly increased the proportion of patients remaining at originating sites, optimizing both tertiary and local centers’ resources. The value of a regional telestroke hub is further underscored by the significant increase in statewide IVT attributed to network consults. However, further strategies are needed to better educate rural providers on acute stroke to reduce the rate of ineligible consults and streamline use of telestroke services.
Abstract TP253: Early Neurological Deterioration Following Small Subcortical Infarcts: A Systematic Review and Meta-Analysis
Chahien, Dalia, Shu, Liqi , Furie, Karen L. , Goldstein, Eric , Muppa, Jayachandra , Yang, Dixon , Gutierrez, José , Meschia, James F. , Yaghi, Shadi

Mayo Clinic

Stroke | February 1, 2024 | Volume: 55 | Issue: Suppl_1 | Pages: No page available

10.1161/str.55.suppl_1.tp253 Get It

Background and Objectives: Acute small subcortical infarcts (SSI) result in high rates of early neurological deterioration (END) despite best medical management. Those with SSI-related END have worse functional outcomes after stroke leading to increased morbidity. Presently, it is unknown in a robust manner the incidence or risk factors for END within this demographic. The aim of this study was to perform a systematic review and meta-analysis to understand the incidence and risk factors of SSI-related END. Methods: We searched PubMed, Cochrane Library, and Google Scholar between January 1, 2000, and June 1, 2022, including both retrospective cross-sectional and prospective observational studies. The primary outcome was development of END based on publishing authors’ definition. Abstracted data included age, sex, cohort size, diagnoses of hypertension, hyperlipidemia, diabetes mellitus, study definition of END and SSI, and presence of branch atheromatous disease (BAD) and lesion diameter. Results: We identified 31 studies enrolling 6376 patients. Most studies were conducted in East Asia (27/31, 87%) and had a least some concern for risk of bias. Funnel plot illustrated a high level of publication bias favoring high incidence studies. END was commonly defined as ≥ 2 overall NIHSS change or ≥ 1 motor change within 3 to 7 days from admission (average: 5 days). A pooled proportion of END was 22% (95%CI 0.19 - 0.25, I2 = 91.2%, 31 studies). Meta-regression identified that female sex [risk ratio (RR) 1.23, 95%CI 1.09-1.39, I2=30.8%, 31 studies], diabetes mellitus (RR 1.16 95%CI 1.01-1.33, I2=38.4%, 30 studies), and BAD (RR 1.99 95%CI 1.61-2.46, I2=50.7%, 17 studies) as risk factors for END. Discussion: Our data identified primarily within an East Asian cohort that risk factors for SSI-related END include diabetes mellitus and branch atheromatous disease with a pooled prevalence of END occurring in 1 in 4 patients. Future studies are needed to understand treatment and preventative strategies for this patient population.
The relationship between performance validity testing, external incentives, and cognitive functioning in long COVID
Whiteside, Douglas M. , Basso, Michael R. , Shen, Chen , Fry, Laura, Naini, Savana M. , Waldron, Eric J. , Holker, Erin , Porter, Jim, Eskridge, Courtney, Logemann, Allison, Minor, Greta , Whiteside, Douglas , Porter, Jim

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | February 1, 2024 | Volume: 46 | Issue: 1 | Pages: 6-15

10.1080/13803395.2024.2312625 | PMID 38299800 Get It

Abstract PR09: Functional and clinical characterization of hypomorphic missense variants in the BRCA2 cancer predisposition gene
Abozaid, Mohamed , Munankarmy, Amik , Rao, Tara, Couch, Ronan E. , Persons, Benjamin R., Pesaran, Tina , Huang, Huaizhi , Hu, Chunling , Na, Jie , Abozaid, Mohamed, Lumby, Carolyn A. , Lyra, Paulo C. , Polley, Eric C. , Karam, Rachid , Yadav, Siddhartha , Monteiro, Álvaro N.A. , Boddicker, Nicholas , Domchek, Susan M. , Richardson, Marcy E , Couch, Fergus J.

Mayo Clinic

Cancer Research | February 1, 2024 | Volume: 84 | Issue: 3_Supplement_1 | Pages: PR09-PR09

10.1158/1538-7445.advbc23-pr09 Get It

Abstract Many germline BRCA2 missense variants of uncertain significance (VUS) remain to be clinically classified as pathogenic or benign. Here we identify 70 missense VUS in the DNA binding domain (DBD) of BRCA2 that partially reduced homologous recombination DNA repair activity of the protein in a homology directed DNA repair cell-based assay. CRISPR/cas9-based knockin of these variants reduced cell survival of haploid cells and conferred increased sensitivity to the PARP inhibitor Olaparib. Sequence alignment analysis found that the variants were highly conserved across species from pufferfish to human. Structural analysis showed that these variants are located predominantly in unstructured regions of the DBD. Case-control association studies showed that the hypomorphic variants conferred moderate risks of breast (OR:2.85; 95%CI:1.43-5.88) and ovarian cancer (OR:3.37; 95%CI:1.30-8.54) that were significantly different from risks associated with known pathogenic and benign variants. Cumulative lifetime risks of breast and ovarian cancer among carriers were estimated at 25% and 4.7%, respectively. Age at diagnosis of breast cancer among hypomorphs carriers was 55 years of age as opposed to 48 years of age for carriers of pathogenic variants. In addition, the combination of functional and other genetic data in an ACMG/AMP-like variant classification model reclassified 39 variants as likely pathogenic. This novel group of low penetrance missense variants further calibrate BRCA2 variant classification methods and have significant implications for the management of variant carriers. Citation Format: Huaizhi (Gilbert) Huang, Chunling Hu, Jie Na, Mohamed Abozaid, Amik Munankarmy, Tara Rao, Carolyn A. Dunn Lumby, Paulo Cilas Morais Lyra, Ronan E. Couch, Benjamin R. Persons, Eric C. Polley, Rachid Karam, Tina Pesaran, Siddhartha Yadav, Alvaro N.A. Monteiro, Nicholas J. Boddicker, Susan M. Domchek, Marcy E. Richardson, Fergus J. Couch. Functional and clinical characterization of hypomorphic missense variants in the BRCA2 cancer predisposition gene [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr PR09.
In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals
Iovleva, Alina , McElheny, Christi L. , Fowler, Erin L., Cober, Eric , Herc, Erica , Arias, César A. , Hill, Carol , Baum, Keri, Fowler, Vance G. , Chambers, Henry F. , Greenwood‐Quaintance, Kerryl E. , Patel, Robin , van Duin, David , Bonomo, Robert A , Doi, Yohei , Hill, Carol , Arias, César A. , Fowler, Vance G. , Patel, Robin , Bonomo, Robert A. , Doi, Yohei

Mayo Clinic

Antimicrobial Agents and Chemotherapy | January 30, 2024 | Volume: 68 | Issue: 3 | Pages: No page available

10.1128/aac.01258-23 | PMID 38289078 Get It

ABSTRACT The activity of a novel β-lactamase inhibitor combination, sulbactam-durlobactam (SUL-DUR), was tested against 87 colistin-resistant and/or cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii clinical isolates collected from U.S. hospitals between 2017 and 2019. Among them, 89% and 97% were susceptible to SUL-DUR and imipenem plus SUL-DUR, with MIC 50 /MIC 90 values of 2 µg/mL/8 µg/mL and 1 µg/mL/4 µg/mL, respectively. The presence of amino acid substitutions in penicillin-binding protein 3, including previously reported A515V or T526S, was associated with SUL-DUR non-susceptibility.
AI-based morphologic model for prediction of individual patient response to immune checkpoint inhibitors for bladder cancer.
Nair, Monica, Xie, Chensu, Basu, Hirak S. , Wilding, George, Roy, Rajat , Díaz‐Montero, C. Marcela , Hwang, Tae Hyun , Dawsey, Scott J. , Nguyen, Jane , Klein, Eric A. , Gupta, Shilpa , Klein, Eric A , Liao, Ross S. , Jain, Parag , Hassan, Muhammad , Huang, Wei , Mian, Omar Y.

Mayo Clinic

Journal of Clinical Oncology | January 29, 2024 | Volume: 42 | Issue: 4_suppl | Pages: 686-686

10.1200/jco.2024.42.4_suppl.686 Get It

686 Background: Immune checkpoint inhibitors (ICI) have been used to treat advanced muscle invasive and/or metastatic bladder cancer. However, ICIs are only effective in 30-40% of cases. In light of potentially significant IRAE’s, tools to predict individual patient level benefits are desirable. AI technology offers the opportunity to apply computational methods to predict outcomes from readily available digitized pathology slides. We investigated the utility of an AI platform integrating computational biomarkers based on morphological characterization of digitized H&E slide whole images (WSI) to predict response to ICI. Methods: We analyzed H&E-stained whole slide images (WSI) of bladder tumor tissue collected from transurethral resection of bladder tumor (TURBT) from 116 patients with advanced or metastatic bladder cancer at a single institution between 2015-2020. Adjacent multiplex IHC stained specimens were analyzed myeloid and lymphoid marker panels. 20 patients from the overall cohort treated with ICI were designated ‘responders’ (complete response, partial response, stable disease) and 20 patients were identified as non-responders (progressive disease) based on ICI best clinical/radiographic response. WSIs were divided into small non-overlapping image patches. These image tiles were processed into multiple AI encoder models to extract morphological features. The tile morphological features, represented by high dimensional vectors, were combined by an aggregation model to represent the whole slide morphology and then used to classify the patients into responders vs non-responders to immunotherapy. Area-under-the-receiver operating characteristic (AUC) was used to measure the performance of response prediction. Results: Our method shows AUC of 0.708 at classification of the patients (n=40) into responder and non-responder groups. With a cutoff that identifies the top 50% patients (n=20) of high probability of responding to immunotherapy predicted by our models, 75% of them are responders. In the bottom 50% patients (n=20) of the low scores, 75% of them are non-responders. . Multiplex IHC (myeloid and lymphoid panel) was performed using adjacent sections and were characterized yielding deeper mechanistic insight into the inflammatory populations driving predictive morphologic patterns. Conclusions: By applying innovative AI morphological analysis on patient WSIs, we generated a computational biomarker that shows promising ability to predict patient response to immunotherapy in bladder cancer. This approach merits future prospective validation and additional patient level analysis in broader cohorts. [Table: see text]
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
Barbour, Sean J. , Coppo, Rosanna , Er, Lee, Pillebout, Évangéline , Russo, María Luisa , Alpers, Charles E. , Ferrario, Franco, Jennette, J. Charles , Roberts, Ian S.D. , Cook, H. Terence , Ding, Jie , Su, Baige , Zhong, Xuhui, Zand, Ladan , Lucchetti, Laura , Katafuchi, Ritsuko , Shima, Yuko , Yoshikawa, Norishige, Ichikawa, Daisuke , Suzuki, Yusuke , Park, Catherine , Nelson, Raoul D., Narus, JoAnn Hansen , Wenderfer, Scott E. , Monteiro, Renato C. , Nakatani, Shinya , Mastrangelo, Antonio , Nuutinen, Matti, Koskela, Mikael , Weber, Lutz T. , Hackl, Ágnes, Pecoraro, Carmine, Yokoo, Takashi , Ito, Takafumi, Conti, Giovanni , Materassi, Marco , Zhang, Hong , Shi, Sufang , Liu, Zhihong , Ávila-Casado, Carmen , Bajema, Ingeborg M., Barreca, Antonella , Comstock, Jessica, Cornea, Virgilius , Eldin, Karen W. , Hernandez, Loren Herrera, Hou, Jean , Lin, Mercury, Messias, Nidia , Tokola, Heikki , DʼArmiento, Maria , Sannier, Aurélie , Jennette, J Charles , Ding, Jie , Zand, Ladan , Peruzzi, Licia , Shima, Yuko , Ichikawa, Daisuke , Suzuki, Yusuke , Narus, JoAnn H , Wenderfer, Scott E , Geetha, Duvuru , Daugas, Eric , Monteiro, Renato C , Tsuboi, Nobuo , Yokoo, Takashi , Fujimoto, Shouichi , Materassi, Marco , Shi, Sufang , Liu, Zhi-Hong , Tesar, Vladimir , Maixnerova, Dita , Barreca, Antonella , Eldin, Karen , Joh, Kensuke , Muda, Andrea Onetti , Pagni, Fabio , Diomedi-Camassei, Francesca , Tokola, Heikki , Seidl, Maximilian , Sannier, Aurélie , Soares, Maria Fernanda , Wang, Suxia , Zeng, Caihong , Coppo, Rosanna , Fogo, Agnes B. , Fervenza, Fernando C. , Murer, Luisa , Wyatt, Robert J. , Pohl, Martin, Santoro, Domenico , Tesař, Vladimı́r , Becker, Jan Ulrich , Diomedi‐Camassei, Francesca , Rosenberg, Avi Z. , Haas, Mark

Mayo Clinic

Clinical Journal of the American Society of Nephrology | January 23, 2024 | Volume: 19 | Issue: 4 | Pages: 438-451

10.2215/cjn.0000000000000398 | PMID 38261310 Get It

Background Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts. Methods Biopsies from 262 children and 99 adults with IgA vasculitis nephritis ( N =361) from 23 centers in North America, Europe, and Asia were independently scored by three pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients ( N =309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using latent class mixed models to identify classes of eGFR trajectories over a median follow-up of 2.7 years (interquartile range, 1.2–5.1). Clinical and histologic parameters associated with each class were determined using logistic regression. Results M, E, T, and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by latent class mixed model, one with initial improvement in eGFR followed by a late decline (class 1, N =91) and another with stable eGFR (class 2, N =218). Class 1 was associated with a higher risk of an established kidney outcome (time to ≥30% decline in eGFR or kidney failure; hazard ratio, 5.84; 95% confidence interval, 2.37 to 14.4). Among MEST-C scores, only E1 was associated with class 1 by multivariable analysis. Other factors associated with class 1 were age 18 years and younger, male sex, lower eGFR at biopsy, and extrarenal noncutaneous disease. Fibrous crescents without active changes were associated with class 2. Conclusions Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.